Research / ALSN / Fundamental state Inspectable configuration
State dimensions Filing 0000950170-22-014503 General Corporate
Debt relative to revenue 38th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.debt_to_revenue
380.72% · OPTIONAL · VALID
Capex intensity 25th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.capex_revenue_ratio
4.52% · OPTIONAL · VALID
Operating cash generation 0th Own-history percentile · N=8
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
9.94% · OPTIONAL · VALID
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
10.12% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure 75th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
34.34% · OPTIONAL · VALID
Gross margin 25th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.gross_margin
46.84% · CORE · VALID
Operating margin 75th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.operating_margin
28.16% · CORE · VALID
R&D intensity 50th Own-history percentile · N=8
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
6.93% · OPTIONAL · VALID
SBC intensity 88th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.90% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 25 states Self-history eligible
Sep 30, 2021 0/9 normalized Level 3 Dec 31, 2021 0/9 normalized Level 3 Mar 31, 2022 0/9 normalized Level 3 Jun 30, 2022 8/9 normalized Level 3 Sep 30, 2022 8/9 normalized Level 3 Dec 31, 2022 8/9 normalized Level 3 Mar 31, 2023 8/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 9/9 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 373.71%
Current 380.72%
Delta 7.02% Capex Intensity Increased
Previous 2.95%
Current 4.52%
Delta 1.56% Cash Generation Decreased
Previous 24.08%
Current 9.94%
Delta -14.14% Growth Decreased
Previous 15.14%
Current 10.12%
Delta -5.02% Inventory Pressure Increased
Previous 31.02%
Current 34.34%
Delta 3.32% Margin Decreased
Previous 47.27%
Current 46.84%
Delta -0.43% Profitability Decreased
Previous 29.84%
Current 28.16%
Delta -1.67% R And D Intensity Increased
Previous 6.35%
Current 6.93%
Delta 0.58% Sbc Intensity Increased
Previous 0.44%
Current 0.90%
Delta 0.46% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.